{"id":"https://openalex.org/W93009160","doi":null,"title":"Aclarubicin: experimental and clinical experience.","display_name":"Aclarubicin: experimental and clinical experience.","publication_year":1985,"publication_date":"1985-01-01","ids":{"openalex":"https://openalex.org/W93009160","mag":"93009160","pmid":"https://pubmed.ncbi.nlm.nih.gov/3915280"},"language":"en","primary_location":{"id":"pmid:3915280","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3915280","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs under experimental and clinical research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040874242","display_name":"H.-J. R\u00f6thig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H J R\u00f6thig","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110172222","display_name":"H. P. Kraemer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H P Kraemer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110479503","display_name":"H.H. Sedlacek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H H Sedlacek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3852,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.50254703,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"11","issue":"2","first_page":"123","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.3188000023365021,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.3188000023365021,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.28690001368522644,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.16820000112056732,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aclarubicin","display_name":"aclarubicin","score":1.0},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.9679999947547913},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7960000038146973},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8230000138282776},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8529999852180481},{"id":"https://openalex.org/keywords/thyroid-cancer","display_name":"thyroid cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6510000228881836},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8579999804496765},{"id":"https://openalex.org/keywords/doxorubicin-comparison","display_name":"doxorubicin comparison","score":0.703000009059906},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.6359999775886536},{"id":"https://openalex.org/keywords/6-thioguanine","display_name":"6-thioguanine","score":0.9670000076293945}],"concepts":[{"id":"https://openalex.org/C2780847677","wikidata":"https://www.wikidata.org/wiki/Q4674302","display_name":"Aclarubicin","level":4,"score":0.9706131219863892},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.832103967666626},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.7851443290710449},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.7566275596618652},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.740101158618927},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.7305281162261963},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5226185917854309},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5166555047035217},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5082106590270996},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.4871182441711426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4672510623931885},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4582691490650177},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.443718820810318},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3238633871078491},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.2677406668663025},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.18069833517074585}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003114","descriptor_name":"Colony-Forming Units Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007939","descriptor_name":"Leukemia L1210","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007948","descriptor_name":"Leukemia, Monocytic, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009279","descriptor_name":"Naphthacenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009279","descriptor_name":"Naphthacenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015250","descriptor_name":"Aclarubicin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3915280","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3915280","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs under experimental and clinical research","raw_type":"Clinical Trial"},{"id":"mag:93009160","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3915280","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2409795875","https://openalex.org/W2008489711","https://openalex.org/W4399319580","https://openalex.org/W1973526655","https://openalex.org/W2412758982","https://openalex.org/W2401264415","https://openalex.org/W4254242670","https://openalex.org/W4388966075","https://openalex.org/W4411036387","https://openalex.org/W2411200461"],"abstract_inverted_index":{"Aclarubicin,":[0],"discovered":[1],"by":[2],"Umezawa":[3],"in":[4,109,116,126,129,148],"1975,":[5],"is":[6,13,23,42],"a":[7,51],"new":[8],"cytostatic":[9],"anthracycline":[10],"antibiotic.":[11],"It":[12],"one":[14],"of":[15,30,36,46,58,74,119],"the":[16,19,145,149],"anthracyclines":[17],"with":[18,112,131,139],"lowest":[20],"cardiotoxicity,":[21],"it":[22,27],"not":[24,178],"mutagenic":[25],"and":[26,48,76,94,134,142,166,184],"stimulates":[28],"differentiation":[29],"tumour":[31],"cells.":[32],"The":[33],"therapeutic":[34],"index":[35],"aclarubicin":[37,59],"(efficacy":[38],"related":[39],"to":[40,72,105],"toxicity)":[41],"higher":[43],"than":[44],"that":[45,73],"doxorubicin":[47,75],"daunorubicin,":[49],"using":[50],"proper":[52],"dose":[53,56,67,83,175],"schedule.":[54],"Single":[55],"therapy":[57,68],"shows":[60],"only":[61],"marginal":[62],"efficacy,":[63],"whereas":[64],"multiple":[65],"divided":[66],"exhibits":[69],"efficacy":[70,146],"comparable":[71],"daunorubicin.":[77],"Thus":[78],"for":[79,91,99,156],"clinical":[80,137],"trials":[81,138],"two":[82],"schedules":[84],"were":[85,123,160,169],"designed:":[86],"25":[87],"mg/m2/day,":[88,96],"days":[89,97],"1-7":[90],"acute":[92,110,127],"leukaemia;":[93],"30":[95],"1-4":[98],"solid":[100],"tumours.":[101],"Aclarubicin":[102],"was":[103,147,172,177,181],"shown":[104],"be":[106,154],"highly":[107],"active":[108],"leukaemia":[111,128],"58%":[113],"complete":[114],"remissions":[115],"first":[117],"relapse":[118],"AML.":[120],"Good":[121],"results":[122],"also":[124],"seen":[125],"combination":[130],"cytosine":[132],"arabinoside":[133],"thioguanine.":[135],"In":[136],"breast":[140],"cancer":[141,144],"thyroid":[143],"same":[150],"range":[151],"as":[152],"would":[153],"expected":[155],"doxorubicin,":[157],"but":[158,174],"side-effects":[159],"markedly":[161],"reduced.":[162],"Anorexia,":[163],"mild":[164],"nausea":[165],"infrequent":[167],"vomiting":[168],"observed.":[170],"Myelosuppression":[171],"common":[173],"reduction":[176],"necessary.":[179],"There":[180],"no":[182,185],"alopecia":[183],"congestive":[186],"heart":[187],"failure.":[188]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}